All In Biotech

Free tool

FAERS Monitor: Lasix Onyu

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 217294 or its brand name (Lasix Onyu, Furosemide). Reports on generic versions are filed under their own applications.

Reports

265,538

Serious

219,231

83% of reports

Hospitalization

129,766

Death reported

40,876

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea18,437
  • acute kidney injury16,467
  • fatigue13,248
  • diarrhoea13,195
  • death12,368
  • nausea11,534
  • fall11,003
  • off label use10,842
  • drug ineffective10,424
  • hypotension10,330
  • pneumonia10,172
  • dizziness9,887
  • asthenia9,287
  • headache8,706
  • pain8,196

Reports by year received

View as table
YearReports
20043,479
20053,857
20063,623
20073,214
20083,608
20093,997
20104,832
20116,479
20127,274
20137,405
201410,059
201513,254
201616,201
201716,716
201821,192
201923,004
202020,355
202118,734
202216,306
202316,473
202417,411
202516,227
202611,831

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,788,621 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal16,4679.49.3111,550
hypotensionSignal10,3304.24.224,546
fallSignal11,0032.72.611,327
dyspnoeaSignal18,4372.62.618,561
pneumoniaSignal10,1722.52.59,315
asthenia9,2872.01.94,476
diarrhoea13,1951.61.63,263
dizziness9,8871.61.62,123
fatigue13,2481.41.31,250
nausea11,5341.21.1250
death12,3681.11.1216
headache8,7061.11.182
pain8,1961.11.026
off label use10,8421.01.04
drug ineffective10,4240.60.62,508

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.